Skip to main content
. 2018 Mar;10(3):1476–1482. doi: 10.21037/jtd.2018.01.177

Table 2. Distributions of the CHA2DS2-VASc and CHADS2 scores.

CHADS2 score N (%) CHADS2 redistribution to CHA2DS2-VASc score CHA2DS2-VASc N (%)
0 15 (13.6) 0: 4 (26.6) 0 4 (3.6)
1: 5 (33.3)
2: 4 (26.6)
3: 2 (13.3)
1 34 (30.9) 1: 4 (11.7) 1 9 (8.2)
2: 12 (35.2)
3: 14 (41.1)
4: 4 (11.7)
2 21 (19.1) 2: 3 (14.2) 2 19 (17.3)
3: 7 (33.3)
4: 7 (33.3)
5: 4 (19.0)
3 23 (20.9) 3: 2 (8.6) 3 25 (22.7)
4: 7 (30.4)
5: 11 (47.8)
6: 3 (13.0)
4 10 (9.1) 5: 2 (20.0) 4 18 (16.3)
6: 6 (60.0)
7: 2 (20.0)
5 6 (5.4) 6: 2 (33.3) 5 17 (15.4)
7: 3 (50.0)
8: 1 (16.6)
6 1 (0.9) 8: 1 (100.0) 6 11 (10.0)
7 5 (4.5)
8 2 (1.8)

Values represent the CHADS2 score redistribution applying the CHA2DS2-VASc score. CHADS2 = congestive heart failure (1 point), hypertension (1 point), age ≥75 years (1 point), diabetes mellitus (1 point) and previous stroke/transient ischemic accident (2 points); CHA2DS2-VASc = congestive heart failure (1 point), hypertension (1 point), age ≥75 years (2 points), diabetes mellitus (1 point), previous stroke/transient ischemic accident (2 points), vascular disease (1 point), age 65–75 years (1 point) and female gender (1 point).